Babies born to mothers who took selective serotonin reuptake inhibitors were more likely to have reduced head growth, a Dutch study found. Mothers with untreated depression were more likely to give birth to babies with overall reduced growth. Researchers also found that mothers who used SSRIs had a higher risk of preterm birth compared with mothers without depression. The findings appear in the Archives of General Psychiatry.
AHIP President Karen Ignagni also discussed the proposal in a Newsmaker session with USA TODAY. "This is a major step, and it changes everything about how the market works," she said. Read a live blog of the session.